Analysts Set The Clorox Company (NYSE:CLX) Target Price at $122.88

The Clorox Company (NYSE:CLXGet Free Report) has been given an average recommendation of “Reduce” by the nineteen brokerages that are currently covering the stock, Marketbeat.com reports. Four research analysts have rated the stock with a sell rating, fourteen have issued a hold rating and one has issued a buy rating on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $122.6250.

A number of analysts have weighed in on the company. JPMorgan Chase & Co. reduced their price target on Clorox from $127.00 to $120.00 and set a “neutral” rating for the company in a research report on Tuesday, November 4th. BNP Paribas Exane reduced their target price on Clorox from $110.00 to $103.00 and set an “underperform” rating for the company in a report on Tuesday, November 4th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Morgan Stanley lowered their price target on Clorox from $137.00 to $125.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 4th. Finally, UBS Group reduced their price objective on shares of Clorox from $119.00 to $115.00 and set a “neutral” rating for the company in a research note on Wednesday.

Get Our Latest Research Report on Clorox

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction dated Friday, November 21st. The shares were acquired at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the completion of the purchase, the director owned 13,000 shares of the company’s stock, valued at approximately $1,353,690. This trade represents a 44.44% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.63% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in CLX. Invesco Ltd. grew its stake in shares of Clorox by 138.3% in the second quarter. Invesco Ltd. now owns 3,245,175 shares of the company’s stock worth $389,648,000 after acquiring an additional 1,883,465 shares during the last quarter. Norges Bank acquired a new stake in Clorox in the 2nd quarter worth $190,429,000. Van ECK Associates Corp grew its position in Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after purchasing an additional 1,312,471 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its holdings in shares of Clorox by 218.4% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company’s stock worth $149,983,000 after purchasing an additional 856,873 shares during the period. Finally, Worldquant Millennium Advisors LLC acquired a new position in shares of Clorox during the second quarter valued at about $71,856,000. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

NYSE CLX opened at $111.35 on Monday. The company has a quick ratio of 0.50, a current ratio of 0.76 and a debt-to-equity ratio of 18.01. The stock has a market capitalization of $13.58 billion, a PE ratio of 17.48, a price-to-earnings-growth ratio of 0.54 and a beta of 0.58. Clorox has a 12-month low of $96.66 and a 12-month high of $164.22. The company has a 50 day moving average price of $102.98 and a two-hundred day moving average price of $115.42.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.68% and a return on equity of 358.39%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same quarter last year, the firm earned $1.86 EPS. Clorox’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Wednesday, January 28th will be issued a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.5%. The ex-dividend date is Wednesday, January 28th. Clorox’s dividend payout ratio is 77.86%.

About Clorox

(Get Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

See Also

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.